Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority

Abstract

ObjectiveTo estimate the economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015.DesignA retrospective review of data.SettingTanzania Food and Drugs Authority and premises dealing with importations and distributions of pharmaceuticals.Eligibility criteriaConfiscation reports of substandard human medicines, falsified human medicines and cosmetics with banned ingredients.Primary and secondary outcome measuresQuantities and costs of pharmaceutical products, costs of transportation, storage, court cases and disposal of products.ResultsThe economic cost of substandard and falsified human medicines and cosmetics with banned ingredients was estimated at US$16.2 million, that is, value of substandard medicines US$13.7 million (84.4%), falsified medicines US$0.1 million (1%), cosmetics with banned ingredients US$1.3 million (8%) and other/operational costs US$1.1 million (6.6%). Some of the identified substandard and falsified human medicines include commonly used antibiotics such as phenoxymethylpenicillin, amoxicillin, cloxacillin and co-trimoxazole; antimalarials such quinine, sulfadoxine–pyrimethamine, sulfamethoxypyrazine–pyrimethamine and artemether–lumefantrine; antiretroviral drugs; antipyretics and vitamins among others.ConclusionThe economic cost of substandard and falsified human medicines and cosmetics with banned ingredients represent a relatively large loss of scarce resources for a poor country like Tanzania. We believe that the observed increase in the quantities and the economic cost of these products over time could partly be due to the improvement in the regulatory capacity in terms of human resources, infrastructure and frequency of inspections.

A Survey on Using Blockchain in Trade Supply Chain Solutions

“…Trading counterfeit goods have a significant negative, damaging impact on society and the economy. For instance, trading fake medicines not only has a dangerous outcome on people's health and, thus, on their life but also costs the economy millions of dollars [34], [35]. Thus, establishing an efficient mechanism for anti-counterfeit has always been a priority for the public and private sectors.…”

Tanzanian primary healthcare workers’ experiences of antibiotic prescription and understanding of antibiotic resistance in common childhood infections: a qualitative phenomenographic study

“…This is causing huge economic losses and an estimated 150,000–400,000 unnecessary child deaths due to malaria and childhood pneumonia [ 52 ]. A study on the cost of confiscated falsified and substandard medicines and cosmetics by the Tanzanian authorities between 2005 and 2015 showed an increase in quantity and cost of these products over time, which may in part reflect increased regulatory capacity [ 54 ]. For antimicrobials, falsified or substandard antimalarials have been mostly studied [ 55 – 57 ].…”

Tanzanian primary healthcare workers’ experiences of antibiotic prescription and understanding of antibiotic resistance in common childhood infections: A qualitative phenomenographic study

“…This is causing huge economic losses and an estimated 150,000 -400,000 unnecessary child deaths due to malaria and childhood pneumonia (52). A study on the cost of con scated falsi ed and substandard medicines and cosmetics by the Tanzanian authorities between 2005 and 2015 showed an increase in quantity and cost of these products over time, which may in part re ect increased regulatory capacity (54). For antimicrobials, falsi ed or substandard antimalarials have been mostly studied (55)(56)(57).…”